Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,135.00    5.00 (0.07%)
Bid:
7,130.00
Ask:
7,140.00
Spread: 10.00 (0.14%)
Market Cap: £9.57b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Director/PDMR Shareholding

21 Nov 2019 16:00

RNS Number : 2642U
Diploma PLC
21 November 2019
 

 

DIPLOMA PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

 

FOR IMMEDIATE RELEASE

 

21 November 2019

 

 

DIPLOMA PLC (the "Company")

 

DIRECTOR / PDMR Dealings

 

Diploma PLC has been notified that Nigel Lingwood has exercised his options over 55,035 Ordinary Shares of 5p each in the Company ("Shares"). These options vested in relation to a share award granted on 22 December 2016 under the Diploma PLC 2011 Performance Share Plan ("PSP"). As a consequence, Nigel Lingwood has become entitled to acquire Shares in the Company as set out below.

 

This award crystallised after meeting performance conditions measured over a three-year period ended 30 September 2019. Further details relating to the performance conditions of these awards are set out in the Annual Report & Accounts 2019, which will be mailed to shareholders on 6 December 2019.

 

The number of Shares acquired by Nigel Lingwood has been reduced as part of arrangements under which the Company will settle the PAYE liability of Nigel Lingwood which arises as a result of the exercise of the options. The table below shows the total number of Shares vested, the PAYE adjustment on the vested Shares and the net number of Shares acquired by Nigel Lingwood.

 

Number of Shares

Total Shares Vested

PAYE Adjustment

Total Shares Acquired

 

Market Price

NP Lingwood

55,035

(25,866)

29,169

1755p

 

Following the above transaction, Nigel Lingwood disposed of 29,169 Shares on 20 November 2019 at a price of £17.55. After this transaction, Nigel Lingwood retains 100,000 shares in the Company which represents 0.09% of the issued share capital.

 

The notification set out below has been made in accordance with Article 19 of the EU Market Abuse Regulation.

 

 

 

 

1

 

Details of the Director/PDMR/PCA

 

a)

Name

 

NP Lingwood

 

2

 

Reason for the notification

 

a)

Position/Status

 

Group Finance Director

b)

Initial notification/Amendment

 

Initial notification

 

3

 

Details of the issuer

 

a)

Name

 

Diploma PLC

b)

LEI

 

2138008OG17VYG8FGR19

 

4

 

Details of the transactions:

 

a)

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 5p each in the Company

 

 

 

GB0001826634

b)

Nature of the transaction

 

Exercise and sale of shares

c)

Price(s) and volume(s)

 

 

Price

Volume

1755p

29,169

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

1755p

29,169

e)

Date of the transaction

 

20 November 2019

f)

Place of the transaction

 

London Stock Exchange, United Kingdom

 

 

 

 

 

For further information, please contact:

 

Diploma PLC -

+44 (0)20 7549 5700

Anthony Gallagher, Group Company Secretary

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDMMZMDMNGLZM
Date   Source Headline
30th May 20237:00 amRNSAppointment of Non-Executive Director
22nd May 20233:30 pmRNSHolding(s) in Company
15th May 20237:00 amRNSHalf-year Report
3rd Apr 20237:00 amRNSTotal Voting Rights
27th Mar 202310:34 amRNSHolding(s) in Company
24th Mar 20234:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20232:34 pmRNSHolding(s) in Company
22nd Mar 20237:00 amRNSIssue of Shares and Total Voting Rights
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
20th Mar 20239:14 amRNSHolding(s) in Company
17th Mar 20236:00 pmRNSDiploma
17th Mar 20237:00 amRNSResult of Placing
16th Mar 20234:47 pmRNSRetail Offer
16th Mar 20234:46 pmRNSProposed Placing
16th Mar 20234:45 pmRNSAcquisition and M&A Pipeline Update
20th Feb 20239:35 amRNSHolding(s) in Company
9th Feb 20238:27 amRNSHolding(s) in Company
30th Jan 20232:53 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSDirector/PDMR Grant of LTIP Award
18th Jan 202311:13 amRNSResult of AGM
18th Jan 20237:00 amRNSTrading Statement
12th Dec 20227:00 amRNSAnnual Financial Report & Notice of AGM
9th Dec 202210:33 amRNSHolding(s) in Company - Replacement
8th Dec 20229:41 amRNSHolding(s) in Company
1st Dec 20227:00 amRNSTotal Voting Rights
29th Nov 20227:00 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSDirector/PDMR Shareholding
21st Nov 20228:28 amRNSHolding(s) in Company
21st Nov 20227:00 amRNSFinal Results
17th Nov 20227:00 amRNSISSUE OF SHARES AND TOTAL VOTING RIGHTS
12th Oct 20222:06 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSDirector/PDMR Shareholding
8th Sep 20227:30 amRNSDirectorate Change
31st Aug 20227:00 amRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSDirectorate Change
21st Jul 20227:00 amRNSTrading Statement
20th May 20223:19 pmRNSHolding(s) in Company
16th May 20227:00 amRNSHalf-year Report
12th Apr 20227:00 amRNSTrading Statement
8th Mar 20229:36 amRNSHolding(s) in Company
19th Jan 20224:00 pmRNSResult of AGM
19th Jan 20227:00 amRNSTrading Statement
10th Jan 20227:00 amRNSAGM arrangements in light of COVID-19
21st Dec 20217:00 amRNSDirector/PDMR Shareholding
7th Dec 20217:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20217:00 amRNSTotal Voting Rights
30th Nov 20217:00 amRNSDirector/PDMR Shareholding
30th Nov 20217:00 amRNSDirector/PDMR Shareholding
23rd Nov 20217:00 amRNSDirector/PDMR Shareholding
22nd Nov 20217:06 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.